Qdenga

Qdenga

Manufacturer:

Takeda

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Dengue tetravalent vaccine (live, attenuated)
Indications/Uses
Prevention of dengue disease caused by any dengue virus serotype in individuals 4-60 yr.
Dosage/Direction for Use
SC Preferably, inj in upper arm in deltoid region. Individual 4-60 yr at time of 1st inj 0.5 mL at 2-dose (0 & 3 mth) schedule.
Contraindications
Hypersensitivity. Individuals w/ congenital or acquired immune deficiency, including immunosuppressive therapies eg, chemotherapy or high doses of systemic corticosteroids (eg, 20 mg/day or 2 mg/kg/day of prednisone for ≥2 wk) w/in 4 wk prior to vaccination; symptomatic or asymptomatic HIV infection. Pregnancy & lactation.
Special Precautions
Not to be administered by intravascular, intradermal or IM inj. Postpone vaccination in subjects suffering from acute severe febrile illness. Rare anaphylactic reaction. Anxiety-related reactions, including vasovagal reactions (syncope), hyperventilation or stress-related reactions as psychogenic response to the needle of inj. Have a review of medical history. Continue personal protection measures against mosquito bites after vaccination. Patients receiving Ig or blood products containing Ig, eg, blood or plasma should wait for at least 6 wk, & preferably for 3 mth, following end of treatment prior to administration. Administer vaccine at different inj site if to be given at the same time w/ other vaccines. May temporarily minor influence on the ability to drive & use machines. Women of childbearing potential should avoid pregnancy for at least 1 mth following vaccination. Women who intend to become pregnant should be advised to delay.
Adverse Reactions
URTI; decreased appetite; irritability; headache, somnolence; myalgia; inj site pain & erythema, malaise, asthenia, fever. Nasopharyngitis, pharyngotonsillitis; arthralgia; inj site swelling, bruising & pruritus, flu-like illness.
Drug Interactions
Ig or blood products containing Ig eg, blood or plasma. Concomitant use w/ immunosuppressive therapies eg, chemotherapy or high doses of systemic corticosteroids.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BX04 - dengue virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against Dengue virus.
Presentation/Packing
Form
Qdenga powd for soln for inj
Packing/Price
(+ (solvent in pre-filled syringe + 2 needles)) 0.5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in